Oncology Life Sciences Industry Report - Oncology Developments in the oncology space in 2024 brought hope to both industry and patients.
Oncology Sponsored Patient Centricity to Integration: Enhancing Cancer Outcomes We are living in an era of unprecedented advances in cancer treatments with transformative therapies being regularly approved.
White Papers Sponsored How pharma can help the post-COVID recovery of European canc... The new Cancer Care in Europe: Recovering from COVID-19 Disruption white paper assesses the disruption to patient care and the changes physicians i
Oncology Sponsored Preparing for the next decade of innovation in immuno-oncolo... Immuno-oncology has seen some striking clinical advances in the 10 years since the approval of the first therapeutic cancer vaccine, but it’s a field that doesn’t stand still.
Debates & Insight Sponsored From promise to practice: immuno-oncology in action – the ne... Immuno-oncology therapies that harness the body's own defences to fight off tumours are widely acknowledged as the new frontier in cancer treatment.
News Jeito closes 'record' $1.2bn Europe-focused biopharma fund Jeito Capital has closed its second fund, raking in €1bn, which it claims is the largest ever raise for an independent European biopharma fund.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
